In this Review, we have summarized advances in the development of cancer vaccine adjuvants, including chemically engineered molecular agonists, versatile self-adjuvanting materials, and genetically engineered bio-derived materials.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: